Fluoropharma Medical Shares Owned By Institutions vs. Working Capital
| FPMI Stock | USD 0.0001 0.00 0.00% |
For Fluoropharma Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Fluoropharma Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Fluoropharma Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Fluoropharma Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Fluoropharma Medical over time as well as its relative position and ranking within its peers.
Fluoropharma |
Fluoropharma Medical Working Capital vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Fluoropharma Medical's current stock value. Our valuation model uses many indicators to compare Fluoropharma Medical value to that of its competitors to determine the firm's financial worth. Fluoropharma Medical is rated below average in shares owned by institutions category among its peers. It also is rated below average in working capital category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fluoropharma Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fluoropharma Medical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Fluoropharma Working Capital vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Fluoropharma Medical |
| = | 0.34 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Fluoropharma Medical |
| = | (10.23 M) |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Fluoropharma Working Capital Comparison
Fluoropharma Medical is currently under evaluation in working capital category among its peers.
Fluoropharma Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Fluoropharma Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Fluoropharma Medical will eventually generate negative long term returns. The profitability progress is the general direction of Fluoropharma Medical's change in net profit over the period of time. It can combine multiple indicators of Fluoropharma Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Fluoropharma Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Fluoropharma Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Fluoropharma Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Fluoropharma Medical's important profitability drivers and their relationship over time.
Use Fluoropharma Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fluoropharma Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fluoropharma Medical will appreciate offsetting losses from the drop in the long position's value.Fluoropharma Medical Pair Trading
Fluoropharma Medical Pair Trading Analysis
The ability to find closely correlated positions to Fluoropharma Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fluoropharma Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fluoropharma Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fluoropharma Medical to buy it.
The correlation of Fluoropharma Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fluoropharma Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fluoropharma Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fluoropharma Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Fluoropharma Medical position
In addition to having Fluoropharma Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Realty Funds Thematic Idea Now
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Fluoropharma Pink Sheet
To fully project Fluoropharma Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Fluoropharma Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Fluoropharma Medical's income statement, its balance sheet, and the statement of cash flows.